| Centers | ||
| Drug Discovery Core | test | Therapeutic Accelerator Program (TAP) | 
| The Drug Discovery Core at the University of Utah is an established Service/Recharge center that provides compound collections for screening by University of Utah Faculty. Our mission is to provide customers low-cost and efficient access to chemical... | sfgd | Test | 
| Partnerships | Events | Jobs | 
| IBD Therapeutics IncubatorIBD Therapeutics Incubator: Request for ProposalsThe Crohn’s & Colitis Foundation (Foundation) is dedicated to addressing the unmet needs of patients with inflammatory bowel diseases (IBD). The goal of this Request for Proposals (RFP) is to... View all Argenta and ANTABIO Announce Drug Discovery CollaborationArgenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration partner Antabio in an anti-bacterial drug... View all GSK and Yale to partner on drug discovery developmentGlaxoSmithKline (GSK) and Yale University will partner to design a new class of molecules to target disease-causing proteins. This is the latest in a string of deals between Yale’s academic researchers and global pharmaceutical companies. View all | No EVENTS for listing | No Job Posts | 



 
								 
								 
						 		
								 
								
								 
								
								 
								
								 
								
								 
								
								 
								
								